CMPX vs COF · $367.4M cap vs P/E 62, rev $53.43B
Compass Therapeutics Inc. (CMPX) versus Capital One Financial Corporation (COF) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
CMPX does not have a complete income-statement cache yet.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
CMPX currently screens at market cap $367.4M. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Not investment advice. Open the CMPX and COF stock pages for the full models.
Not investment advice.